tiprankstipranks
Quest Diagnostics (DGX)
NYSE:DGX
US Market

Quest Diagnostics (DGX) Earnings Dates, Call Summary & Reports

Compare
900 Followers

Earnings Data

Report Date
Apr 23, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
2.21
Last Year’s EPS
2.04
Same Quarter Last Year
Moderate Buy
Based on 12 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Jan 30, 2025
|
% Change Since: 8.58%
|
Next Earnings Date:Apr 23, 2025
Earnings Call Sentiment|Positive
Quest Diagnostics reported strong revenue growth driven by acquisitions and expansions in Advanced Diagnostics. Despite challenges like weather impacts and pricing pressure in the hospital segment, the overall sentiment remains positive due to strategic acquisitions, improvements in consumer testing, and operational efficiencies.
Company Guidance
During the Quest Diagnostics fourth quarter and full-year 2024 earnings call, the company provided guidance for 2025, emphasizing confidence in its core business strengths. For 2025, Quest Diagnostics expects revenues between $10.7 billion and $10.85 billion, with an organic revenue growth target of approximately 3%, supplemented by growth from acquisitions completed in 2024. Adjusted EPS is projected to range from $9.55 to $9.80, while cash from operations is anticipated to be around $1.45 billion. The company foresees margin expansion driven by organic growth and acquisitions, despite planned investments of $20 million in IT and regulatory compliance. They also noted their Invigorate program's success in delivering a 3% annual cost savings target. Key growth drivers include Advanced Diagnostics and expanded access through acquisitions, such as the integration of LifeLabs in Canada. The guidance reflects expected revenue contributions from the launch of the Haystack MRD test, with anticipated improvements in operational efficiency from ongoing investments in automation and AI.
Strong Revenue Growth
Quest Diagnostics reported impressive revenue growth of nearly 15% in the fourth quarter, including approximately 5% organic growth. For the full year, revenue growth was close to 7%, with 3% attributed to organic growth.
Successful Acquisitions
In 2024, Quest completed eight acquisitions, including LifeLabs in Canada and four hospital outreach lab businesses in the US, which significantly contributed to revenue growth.
Advanced Diagnostics Expansion
Quest expanded its Advanced Diagnostics menu, achieving double-digit growth in several clinical areas, such as brain health, advanced cardiometabolic, autoimmune, and women's health.
Consumer-Initiated Testing Growth
The consumer-facing platform, questhealth.com, saw revenue growth of nearly 50% in the fourth quarter and approximately 40% for the full year, reaching over $60 million.
Operational Excellence
Quest's Invigorate program delivered targeted 3% annual cost savings and productivity improvements, supported by investments in automation and AI.
---

Quest Diagnostics (DGX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DGX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 23, 20252025 (Q1)
2.21 / -
2.04
Jan 30, 20252024 (Q4)
2.19 / 2.23
2.153.72% (+0.08)
Oct 22, 20242024 (Q3)
2.26 / 2.30
2.223.60% (+0.08)
Jul 23, 20242024 (Q2)
2.33 / 2.35
2.32.17% (+0.05)
Apr 23, 20242024 (Q1)
1.86 / 2.04
2.040.00% (0.00)
Feb 01, 20242023 (Q4)
2.11 / 2.15
1.988.59% (+0.17)
Oct 24, 20232023 (Q3)
2.19 / 2.22
2.36-5.93% (-0.14)
Jul 26, 20232023 (Q2)
2.27 / 2.30
2.36-2.54% (-0.06)
Apr 27, 20232023 (Q1)
1.98 / 2.04
3.22-36.65% (-1.18)
Feb 02, 20232022 (Q4)
1.91 / 1.98
3.33-40.54% (-1.35)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

DGX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jan 30, 2025$155.44$164.17+5.62%
Oct 22, 2024$146.65$156.70+6.85%
Jul 23, 2024$145.91$139.58-4.34%
Apr 23, 2024$128.13$134.64+5.08%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Quest Diagnostics (DGX) report earnings?
Quest Diagnostics (DGX) is schdueled to report earning on Apr 23, 2025, TBA Not Confirmed.
    What is Quest Diagnostics (DGX) earnings time?
    Quest Diagnostics (DGX) earnings time is at Apr 23, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is DGX EPS forecast?
          DGX EPS forecast for the fiscal quarter 2025 (Q1) is 2.21.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis